The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gagan Harsh Sharma & PACs
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gagan Harsh Sharma, Managing Director and Promoter of Bliss GVS Pharma, along with Persons Acting in Concert (PACs), acquired 32,818 equity shares through open market purchases on June 23 and June 24, 2025 (6,762 shares and 26,056 shares respectively). This represents a 0.03% increase in their combined holding, taking the promoter group's stake from 35.39% to 35.42% of the company's paid-up share capital. The acquisition was made via open market and there is no encumbrance (pledge/lien) on any shares held. The total equity share capital of the company stands at Rs. 10,54,45,522/-.
This is a small promoter group share purchase indicating continued promoter confidence in the company, though the incremental size is negligible (0.03%). The promoter group remains comfortably below any takeover-related thresholds, with no encumbrance on shares, suggesting no financial stress on the promoter.